Product Image

Contributor Information

  • Name Lambert Dorssers
  • Institute Erasmus University Medical Center (Erasmus MC)

Tool Details

  • Tool name: ZR-75-1 [XII-9] cell line
  • Tool type: Cell Lines
  • Tool sub-type: Continuous
  • Parental cell line: ZR-75-1
  • Organism: Human
  • Tissue: Breast
  • Cancer type: Mammary ductal carcinoma, estrogen independent
  • Disease: Cancer
  • Description: Breast cancer is widely and effectively treated with endocrine treatment. However, in many cases the tumours will eventually progress into an estrogen-independent and therapy-resistant phenotype. Retroviral insertion mutagenesis was used to generate this cell line in order to elucidate the molecular mechanisms underlaying endocrine therapy failure. Using this method the main genes conferring estrogen independence in human breast cancer cells where identified. Genes located in the immediate proximity of the retroviral integration site were characterised. Out of 15 candidate breast cancer antigen resistance (BCAR) genes, seven (AKT1, AKT2, BCAR1, BCAR3, EGFR2, GRB7 and TRERF1/BCAR2) were shown to directly underline estrogen independence. This cell line is part of a panel of 71 cell lines (Cat No 154549-154619) plus the parental (Cat No 154547). These cell lines are a powerful tool for studying the molecular and cellular mechanisms of breast tumour progression, therapy resistance and to test the effectiveness of novel drugs to combat different modes of anti-estrogen insensitivity.
  • Research area: Cancer ; Drug Discovery & Development

  • For Research Use Only

Target Details

Application Details

Handling

  • Format: Frozen
  • Growth medium: RPMI 1640 medium supplemented with 10% heat-inactivated bovine calf serum (RBCS)
  • Storage conditions: Liquid Nitrogen
  • Shipping conditions: Dry ice
  • Mycoplasma free: Yes
  • Biosafety level: 1

Documentation

  • Available on request

References

  •   van Agthoven et al. 2009. Breast Cancer Res Treat. 114(1):23-30. PMID: 18351453.